Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引:85
作者
Escudier, B. [1 ]
Kataja, V. [2 ,3 ]
机构
[1] Inst Gustave Roussy, Villejuif, France
[2] Vaasa Cent Hosp, Dept Oncol, Vaasa, Finland
[3] Kuopio Univ Hosp, SF-70210 Kuopio, Finland
关键词
INTERFERON-ALPHA; DOUBLE-BLIND; SUNITINIB; EFFICACY;
D O I
10.1093/annonc/mdq206
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:v137 / v139
页数:3
相关论文
共 15 条
[1]  
Choueiri TK, 2008, J CLIN ONCOL, V26, P127, DOI 10.1200/JCO.2007.13.3223
[2]   Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial [J].
Escudier, Bernard ;
Pluzanska, Anna ;
Koralewski, Piotr ;
Ravaud, Alain ;
Bracarda, Sergio ;
Szczylik, Cezary ;
Chevreau, Christine ;
Filipek, Marek ;
Melichar, Bohuslav ;
Bajetta, Emilio ;
Gorbunova, Vera ;
Bay, Jacques-Olivier ;
Bodrogi, Istvan ;
Jagiello-Gruszfeld, Agnieszka ;
Moore, Nicola .
LANCET, 2007, 370 (9605) :2103-2111
[3]   Sorafenib in advanced clear-cell renal-cell carcinoma [J].
Escudier, Bernard ;
Eisen, Tim ;
Stadler, Walter M. ;
Szczylik, Cezary ;
Oudard, Stephane ;
Siebels, Michael ;
Negrier, Sylvie ;
Chevreau, Christine ;
Solska, Ewa ;
Desai, Apurva A. ;
Rolland, Frederic ;
Demkow, Tomasz ;
Hutson, Thomas E. ;
Gore, Martin ;
Freeman, Scott ;
Schwartz, Brian ;
Shan, Minghua ;
Simantov, Ronit ;
Bukowski, Ronald M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) :125-134
[4]   PROGNOSTIC-SIGNIFICANCE OF MORPHOLOGIC PARAMETERS IN RENAL-CELL CARCINOMA [J].
FUHRMAN, SA ;
LASKY, LC ;
LIMAS, C .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1982, 6 (07) :655-663
[5]   RESULTS OF TREATMENT OF 255 PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA WHO RECEIVED HIGH-DOSE RECOMBINANT INTERLEUKIN-2 THERAPY [J].
FYFE, G ;
FISHER, RI ;
ROSENBERG, SA ;
SZNOL, M ;
PARKINSON, DR ;
LOUIE, AC .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (03) :688-696
[6]   Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review [J].
Gupta, Kiran ;
Miller, Jeffrey D. ;
Li, Jim Z. ;
Russel, Mason W. ;
Charbonneau, Claudie .
CANCER TREATMENT REVIEWS, 2008, 34 (03) :193-205
[7]   Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor-Targeted Agents: Results From a Large, Multicenter Study [J].
Heng, Daniel Y. C. ;
Xie, Wanling ;
Regan, Meredith M. ;
Warren, Mark A. ;
Golshayan, Ali Reza ;
Sahi, Chakshu ;
Eigl, Bernhard J. ;
Ruether, J. Dean ;
Cheng, Tina ;
North, Scott ;
Venner, Peter ;
Knox, Jennifer J. ;
Chi, Kim N. ;
Kollmannsberger, Christian ;
McDermott, David F. ;
Oh, William K. ;
Atkins, Michael B. ;
Bukowski, Ronald M. ;
Rini, Brian I. ;
Choueiri, Toni K. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (34) :5794-5799
[8]   Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma [J].
Hudes, Gary ;
Carducci, Michael ;
Tomczak, Piotr ;
Dutcher, Janice ;
Figlin, Robert ;
Kapoor, Anil ;
Staroslawska, Elzbieta ;
Sosman, Jeffrey ;
McDermott, David ;
Bodrogi, Istvan ;
Kovacevic, Zoran ;
Lesovoy, Vladimir ;
Schmidt-Wolf, Ingo G. H. ;
Barbarash, Olga ;
Gokmen, Erhan ;
O'Toole, Timothy ;
Lustgarten, Stephanie ;
Moore, Laurence ;
Motzer, Robert J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (22) :2271-2281
[9]   Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma [J].
Motzer, RJ ;
Bacik, J ;
Schwartz, LH ;
Reuter, V ;
Russo, P ;
Marion, S ;
Mazumdar, M .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) :454-463
[10]   Efficacy of everolimus in advanced renal cell carcinoma:: a double-blind, randomised, placebo-controlled phase III trial [J].
Motzer, Robert J. ;
Escudier, Bernard ;
Oudard, Stephane ;
Hutson, Thomas E. ;
Porta, Camillo ;
Bracarda, Sergio ;
Gruenwald, Viktor ;
Thompson, John A. ;
Figlin, Robert A. ;
Hollaender, Norbert ;
Urbanowitz, Gladys ;
Berg, William J. ;
Kay, Andrea ;
Lebwohl, David ;
Ravaud, Alain .
LANCET, 2008, 372 (9637) :449-456